iRhythm Holdings, Inc. (IRTC) Guidance & Earnings Results

On 2026-04-30 iRhythm Holdings, Inc. raised guidance: "Revenue guidance raised to $875-$885M (from prior not explicitly stated but implied increase); adjusted EBITDA margin raised to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IRTCiRhythm Holdings, Inc.Follow IRTC — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 4.0B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
30 Apr 26	Raised	Revenue guidance raised to $875-$885M (from prior not explicitly stated but implied increase); adjusted EBITDA margin raised to 12-13% · full year
19 Feb 26	Raised	FY2026 revenue $870-880M; adj. EBITDA margin 11.5-12.5% · full year
30 Oct 25	Raised	FY2025 revenue guidance raised to $735-740M; adjusted EBITDA margin 8.25-8.75% · full year
31 Jul 25	Raised	FY2025 revenue $720M-$730M; adjusted EBITDA margin 8.0%-8.5% · full year

iRhythm Holdings, Inc. — questions

What guidance did iRhythm Holdings, Inc. give?: On 2026-04-30: "Revenue guidance raised to $875-$885M (from prior not explicitly stated but implied increase); adjusted EBITDA margin raised to 12-13%"
When does iRhythm Holdings, Inc. report earnings?: iRhythm Holdings, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from iRhythm Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.